HIV-seq reveals gene expression differences between HIV-transcribing cells from viremic and suppressed people with HIV

Read full text
Authors: J. Frouard, Sushama Telwatte, Xiaoyu Luo, Natalie Gill, Reuben Thomas, Douglas Arneson, Pavitra Roychoudhury, Atul J. Butte, Joseph K. Wong, Hoh Rebecca, Steven G. Deeks, Sulggi A. Lee
+2 more Nadia R. Roan, Steven A. Yukl
Cited by: 4
References: 105

Abstract

HIV-transcribing cells can perpetuate chronic inflammation in ART-suppressed people with HIV (PWH) and likely contribute to viral rebound after ART interruption. However, these cells are difficult to study using single-cell RNA-seq (scRNA-seq) due to their low frequency and low levels of HIV transcripts, which are usually not polyadenylated. By spiking in capture sequences targeting conserved regions of HIV during scRNA-seq - a new method we call "HIV-seq" - we detect double the mean number of HIV reads per cell from PWH. HIV RNA+ cells are enriched among T effector memory cells during both viremia and ART suppression but exhibit a cytotoxic signature during viremia only. In contrast, HIV-transcribing cells from ART-suppressed timepoints exhibit a distinct anti-inflammatory signature involving elevated TGF-β and diminished IFN signaling. These findings demonstrate that HIV-seq is a useful tool to better understand the mechanisms by which HIV-transcribing cells can persist during ART.

Fields of Study & Subjects

Single-cell and spatial transcriptomics HIV Research and Treatment CRISPR and Genetic Engineering

Publication details

Journal / source
Nature Communications
Publisher
Springer Science and Business Media LLC
Volume
17
Issue
1
Publication date
3 March 2026
Language
EN